Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
NCT Number: NCT00602992
Gamma Knife radiosurgery is a non-invasive technique for the delivery of a single, high dose of radiation to an intra-cranial target. MRI has an established and central role in the treatment planning process and assessment of response to intracranial radiosurgery. Increasing the field strength of MRI from 1.5T to 3T promises to improve the signal, and in turn the quality of images. However, the technology also introduces new limitations, and the role and safety of 3T MRI in the management of patients receiving radiosurgery has not yet been reported. In this pilot study, we will explore the spatial integrity, and incremental image-guidance utility of 3T MRI in patients receiving radiosurgery. The preliminary data acquired in this study will be instrumental to the judicious design and conduct of subsequent definitive clinical trials. Up to fifty patients will be enrolled in this study.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Toronto, Ontario, M5T 2S8, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University Health Network, Toronto
Other
Exploring the Role of 3T MRI in Gamma Knife Radiosurgery: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07716124
Brain Diseases, Brain Metastases
Ljubljana, Slovenia
View Trial DetailsNCT04890028
Brain Diseases, Brain Metastases
Angers, France
View Trial DetailsNCT04545814
Brain Diseases, Brain Metastases
Milwaukee, Wisconsin, United States
View Trial DetailsNCT03714243
Brain Diseases, Brain Metastases
Toronto, Ontario, Canada
View Trial Details